These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 28193660)

  • 1. Antimicrobial Resistance of Escherichia coli Urinary Isolates in the Veterans Affairs Health Care System.
    Morrill HJ; Morton JB; Caffrey AR; Jiang L; Dosa D; Mermel LA; LaPlante KL
    Antimicrob Agents Chemother; 2017 May; 61(5):. PubMed ID: 28193660
    [TBL] [Abstract][Full Text] [Related]  

  • 2. First-Line Antimicrobial Resistance Patterns of Escherichia coli in Children With Urinary Tract Infection in Emergency Department and Primary Care Clinics.
    Ahmed MN; Vannoy D; Frederick A; Chang S; Lawler E
    Clin Pediatr (Phila); 2016 Jan; 55(1):19-28. PubMed ID: 26040907
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nitrofurantoin retains antimicrobial activity against multidrug-resistant urinary Escherichia coli from US outpatients.
    Sanchez GV; Baird AM; Karlowsky JA; Master RN; Bordon JM
    J Antimicrob Chemother; 2014 Dec; 69(12):3259-62. PubMed ID: 25063776
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fluoroquinolone-resistant urinary isolates of Escherichia coli from outpatients are frequently multidrug resistant: results from the North American Urinary Tract Infection Collaborative Alliance-Quinolone Resistance study.
    Karlowsky JA; Hoban DJ; Decorby MR; Laing NM; Zhanel GG
    Antimicrob Agents Chemother; 2006 Jun; 50(6):2251-4. PubMed ID: 16723598
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Susceptibility of antimicrobial-resistant urinary Escherichia coli isolates to fluoroquinolones and nitrofurantoin.
    Karlowsky JA; Thornsberry C; Jones ME; Sahm DF
    Clin Infect Dis; 2003 Jan; 36(2):183-7. PubMed ID: 12522750
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extended-spectrum beta-lactamase-producing Enterobacteriaceae in hospital urinary tract infections: incidence and antibiotic susceptibility profile over 9 years.
    Toner L; Papa N; Aliyu SH; Dev H; Lawrentschuk N; Al-Hayek S
    World J Urol; 2016 Jul; 34(7):1031-7. PubMed ID: 26511749
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of 3789 in- and outpatient Escherichia coli isolates from across Canada--results of the CANWARD 2007-2009 study.
    Lagacé-Wiens PR; Simner PJ; Forward KR; Tailor F; Adam HJ; Decorby M; Karlowsky J; Hoban DJ; Zhanel GG;
    Diagn Microbiol Infect Dis; 2011 Mar; 69(3):314-9. PubMed ID: 21353959
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antimicrobial resistance in outpatient Escherichia coli urinary isolates in Dakar, Senegal.
    Sire JM; Nabeth P; Perrier-Gros-Claude JD; Bahsoun I; Siby T; Macondo EA; Gaye-Diallo A; Guyomard S; Seck A; Breurec S; Garin B
    J Infect Dev Ctries; 2007 Dec; 1(3):263-8. PubMed ID: 19734603
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between antimicrobial consumption and resistance in Escherichia coli.
    Bergman M; Nyberg ST; Huovinen P; Paakkari P; Hakanen AJ;
    Antimicrob Agents Chemother; 2009 Mar; 53(3):912-7. PubMed ID: 19104012
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of lower urinary tract infection caused by multidrug-resistant extended-spectrum-beta-lactamase-producing Escherichia coli with amoxicillin/clavulanate: case report and characterization of the isolate.
    Lagacé-Wiens PR; Nichol KA; Nicolle LE; DeCorby M; McCracken M; Mulvey MR; Zhanel GG
    J Antimicrob Chemother; 2006 Jun; 57(6):1262-3. PubMed ID: 16565157
    [No Abstract]   [Full Text] [Related]  

  • 11. Association between fluoroquinolone resistance and resistance to other antimicrobial agents among Escherichia coli urinary isolates in the outpatient setting: a national cross-sectional study.
    Hwang TJ; Hooper DC
    J Antimicrob Chemother; 2014 Jun; 69(6):1720-2. PubMed ID: 24521853
    [No Abstract]   [Full Text] [Related]  

  • 12. Multidrug resistance of Escherichia coli isolated from the urinary bladder of dogs and cats with suspected urinary tract infections.
    Jańczak D; Górecki P; Stryjek R; Zasada A
    Ann Agric Environ Med; 2024 Jun; 31(2):178-184. PubMed ID: 38940100
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Conventional and molecular epidemiology of trimethoprim-sulfamethoxazole resistance among urinary Escherichia coli isolates.
    Burman WJ; Breese PE; Murray BE; Singh KV; Batal HA; MacKenzie TD; Ogle JW; Wilson ML; Reves RR; Mehler PS
    Am J Med; 2003 Oct; 115(5):358-64. PubMed ID: 14553870
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro activity of nitroxoline against Escherichia coli urine isolates from outpatient departments in Germany.
    Kresken M; Körber-Irrgang B
    Antimicrob Agents Chemother; 2014 Nov; 58(11):7019-20. PubMed ID: 25182654
    [No Abstract]   [Full Text] [Related]  

  • 15. High resistance prevalence towards ampicillin, co-trimoxazole and ciprofloxacin, among uropathogenic Escherichia coli isolates in Mexico City.
    Arredondo-García JL; Amábile-Cuevas CF
    J Infect Dev Ctries; 2008 Oct; 2(5):350-3. PubMed ID: 19745501
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antimicrobial susceptibilities of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in health care-associated urinary tract infection: focus on susceptibility to fosfomycin.
    Cho YH; Jung SI; Chung HS; Yu HS; Hwang EC; Kim SO; Kang TW; Kwon DD; Park K
    Int Urol Nephrol; 2015 Jul; 47(7):1059-66. PubMed ID: 26026972
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibacterial Susceptibilities of Escherichia coli from Community-Acquired Urinary Tract Infections in the Faroe Islands, Associations with Antibacterial Sales, and Comparison with Iceland and Denmark.
    Magnussen MD; Gislason H; Gaini S; Kristinsson KG
    Microb Drug Resist; 2018; 24(1):40-47. PubMed ID: 28537778
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ciprofloxacin and co-trimoxazole resistance and extended spectrum beta-lactamase production in Escherichia coli strains isolated from urinary tract infections.
    Ozden M; Kalkan A; Demirdag K; Kilic SS; Ozdarendeli A
    Int J Antimicrob Agents; 2003 May; 21(5):492-3. PubMed ID: 12727086
    [No Abstract]   [Full Text] [Related]  

  • 19. Antimicrobial Activity of Gepotidacin Tested against Escherichia coli and Staphylococcus saprophyticus Isolates Causing Urinary Tract Infections in Medical Centers Worldwide (2019 to 2020).
    Arends SJR; Butler D; Scangarella-Oman N; Castanheira M; Mendes RE
    Antimicrob Agents Chemother; 2023 Apr; 67(4):e0152522. PubMed ID: 36877017
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antimicrobial resistance of Esherichia coli urinary isolates from primary care patients in Greece.
    Falagas ME; Polemis M; Alexiou VG; Marini-Mastrogiannaki A; Kremastinou J; Vatopoulos AC
    Med Sci Monit; 2008 Feb; 14(2):CR75-79. PubMed ID: 18227764
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.